Yan Shu
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Metabolism, Diabetes, and Cancer 6
- Gut microbiota and health 5
- Wnt/β-catenin signaling in development and cancer 4
- Oncology 19
- Drug Transport and Resistance Mechanisms 14
- Co-authors
- Kathleen M. Giacomini (5 shared papers)Hong‐Hao Zhou (8 shared papers)Richard A. Castro (1 shared paper)Joan C. Lo (1 shared paper)Steven A. Sheardown (1 shared paper)Shuzhong Zhang (1 shared paper)Alexandra G. Ianculescu (1 shared paper)Claire M. Brett (1 shared paper)
- Journals
- Frontiers in Pharmacology (4 papers)British Journal of Clinical Pharmacology (3 papers)Drug Metabolism and Disposition (3 papers)Pharmaceutics (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Yan Shu
69 papers receiving 3.0k citations
Yan Shu's Hit Papers
Peers
Comparison fields: 5 of 129
- Pharmacology 473
- Oncology 870
- Biochemistry 203
- Clinical Biochemistry 152
- Endocrinology, Diabetes and Metabolism 344
Countries citing papers authored by Yan Shu
This map shows the geographic impact of Yan Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Shu more than expected).
Fields of papers citing papers by Yan Shu
This network shows the impact of papers produced by Yan Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Shu. The network helps show where Yan Shu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action Hit paper breakdown → | 2007 | 766 |
| 2 | 2003 | 247 | |
| 3 | 2014 | 191 | |
| 4 | 2001 | 116 | |
| 5 | 2000 | 107 | |
| 6 | 2022 | 107 | |
| 7 | 2017 | 99 | |
| 8 | 2008 | 92 | |
| 9 | 2018 | 81 | |
| 10 | 2001 | 77 | |
| 11 | 2010 | 71 | |
| 12 | 2002 | 71 | |
| 13 | 2001 | 56 | |
| 14 | 1997 | 51 | |
| 15 | 2017 | 49 | |
| 16 | 2010 | 49 | |
| 17 | Role of cytochrome P450 in estradiol metabolism in vitro. | 2001 | 48 |
| 18 | 2015 | 47 | |
| 19 | 1999 | 47 | |
| 20 | 2018 | 42 |
About Yan Shu
Yan Shu is a scholar working on Molecular Biology, Oncology, Pharmacology, Pediatrics, Perinatology and Child Health and Genetics, having authored 72 papers that have together received 3.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacological Effects and Toxicity Studies (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Metabolism, Diabetes, and Cancer (6 papers), Mesenchymal stem cell research (6 papers), Gut microbiota and health (5 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Pharmacology (473 citations), Oncology (870 citations), Biochemistry (203 citations), Clinical Biochemistry (152 citations) and Endocrinology, Diabetes and Metabolism (344 citations). Yan Shu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Kathleen M. Giacomini, Hong‐Hao Zhou, Richard A. Castro, Joan C. Lo, Steven A. Sheardown, Shuzhong Zhang, Alexandra G. Ianculescu, Claire M. Brett, Esteban G. Burchard and Chaline Brown. Their work appears in journals such as Frontiers in Pharmacology, British Journal of Clinical Pharmacology, Drug Metabolism and Disposition, Pharmaceutics and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.